2162 studies found for:    Open Studies | "Drug Therapy"
Show Display Options
Rank Status Study
1 Recruiting Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting
Conditions: Chemotherapy-induced Nausea and Vomiting;   Moderate Emetogenic Chemotherapy
Intervention:
2 Recruiting Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma;   Effects of Chemotherapy
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
3 Recruiting Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Olanzapine
4 Unknown  A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy
Conditions: Breast Cancer;   Chemotherapy;   Neutropenia
Intervention: Other: EW02
5 Recruiting Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy
Conditions: Gastrointestinal Neoplasms;   Colorectal Cancer;   Effects of Chemotherapy;   Tumor Immunity;   Malnutrition
Interventions: Drug: Probiotic;   Drug: placebo(for probiotic)
6 Unknown  Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor
Conditions: Gastric Cancer;   Colorectal Cancer;   Chemotherapy
Interventions: Drug: Nutriall;   Drug: LDEPA;   Drug: Placebo;   Drug: HDEPA;   Drug: Chemotherapy
7 Unknown  Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer
Conditions: Chemotherapy;   Breast Cancer, Metastatic
Intervention: Drug: Cyclophosphamide, Capecitabine, Methotrexate, Celecoxib, Pamidronate (or Zoledronate)
8 Recruiting An N-of-1 Study of Homeopathic Treatment of Fatigue in Patients Receiving Chemotherapy
Conditions: Fatigue;   Effects of Chemotherapy
Interventions: Other: Homeopathic medicine;   Other: Unmedicated lactose/sucrose globule
9 Recruiting Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
Conditions: Breast Cancer;   Bevacizumab;   Neoadjuvant Chemotherapy;   Molecular Targeted Therapy
Intervention: Drug: bevacizumab
10 Recruiting Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm
Conditions: Breast Cancer;   Chemotherapy
Interventions: Drug: Taxotere , Epirubicin;   Drug: E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP
11 Recruiting Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Conditions: Central Nervous System Tumor, Pediatric;   Chemotherapy-induced Nausea and Vomiting;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Procedure: Real Acupressure Band;   Procedure: Placebo Acupressure Band
12 Recruiting Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy
Condition: Chemotherapy Induced Nausea and Vomiting
Interventions: Drug: Olanzapine;   Drug: Aprepitant
13 Recruiting LYmphadenectomy After NeoAdjuvant Chemotherapy
Condition: Advanced Ovarian Cancer (Stage III or IV) After Neoadjuvant Chemotherapy
Intervention: Procedure: Systematic pelvic and aortic lymphadenectomy
14 Recruiting Characterization and Treatment of Chemotherapy Neuropathy
Condition: Chemotherapy-induced Neuropathy
Interventions: Procedure: Photon stimulation;   Procedure: Placebo treatment
15 Recruiting Impact of a Telephonic Monitoring During Inter-treatment Intervals on Emotional State, Quality of Life and Toxicities, on Neo Adjuvant or Adjuvant Chemotherapy-treated Patients
Conditions: Non-metastatic Patients With Breast Cancer;   Non-metastatic Patients With Colon Cancer;   Non-metastatic Patients With Rectal Cancer;   Patients Undergoing Adjuvant Chemotherapy
Intervention: Other: Clinical and psychosocial phone calls
16 Recruiting Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
Conditions: Platinum Sensitive;   BRCA Mutated;   Relapsed Ovarian Cancer;   Following Complete or Partial Response to Platinum Based Chemotherapy
Interventions: Drug: Olaparib 300mg tablets;   Drug: Placebo to match olaparib 300mg
17 Not yet recruiting Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer
Conditions: Adherence to Oral Chemotherapy;   Cancer
Intervention: Device: Mobile App Development
18 Recruiting Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)
Condition: Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
Interventions: Drug: Sancuso patch;   Drug: Kytril inj.+Kytril tab.
19 Not yet recruiting The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma
Condition: Effects of Chemotherapy
Interventions: Drug: Concurrent chemotherapy with cisplatin;   Radiation: Intensity modulated radiotherapy
20 Recruiting Olaparib Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Conditions: Newly Diagnosed;   Advanced Ovarian Cancer;   FIGO Stage III-IV;   BRCA Mutation;   Complete Response;   Partial Response;   First Line Platinum Chemotherapy
Intervention: Drug: Olaparib 300mg tablets

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years